Systematic review and network meta-analysis of overall survival comparing ipilimumab 3mg/kg to alternative therapies in the management of pre-treated patients with unresectable stage III/IV melanoma

P Dequen, P Lorigan, JP Jansen, Baardewijk Mv, MJNM Ouwens, S Kotapati

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1376-1385
    JournalOncologist
    Volume17
    Issue number11
    Publication statusPublished - 28 Sept 2012

    Cite this